Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients.
暂无分享,去创建一个
R. Rosell | M. Taron | M. Margelí | J. Ramírez | J. Sánchez | J. Astudillo | C. Sarries | B. Roig | C. Queralt | J. Sánchez | I. de Aguirre | D. Escuin | J. Manzano | P. L. de Castro
[1] W. Leung,et al. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] Michael J. Terry,et al. HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas , 2002, Oncogene.
[3] G. Pfeifer,et al. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas , 2001, Oncogene.
[4] W. Schlegel,et al. Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] J. Minna,et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. , 2001, Journal of the National Cancer Institute.
[6] J. Herman,et al. A gene hypermethylation profile of human cancer. , 2001, Cancer research.
[7] G. Yang,et al. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. , 2001, Cancer research.
[8] E. Mark,et al. Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer , 2001, Oncogene.
[9] J. Minna,et al. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. , 2001, Cancer research.
[10] S. Warren,et al. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. , 2000, Cancer research.
[11] F. Khuri,et al. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. , 2000, Journal of the National Cancer Institute.
[12] Chun Xing Li,et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 , 2000, Nature Genetics.
[13] F. A. Benko,et al. Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA. , 2000, Journal of the National Cancer Institute.
[14] E. Mark,et al. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. , 1999, Journal of the National Cancer Institute.
[15] M. Higashiyama,et al. A novel molecular staging protocol for non-small cell lung cancer , 1999, Oncogene.
[16] J. Herman,et al. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. , 1999, Cancer research.
[17] Peter A. Jones,et al. DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene , 1997, Oncogene.
[18] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[19] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Ariza,et al. Molecular staging of non-small cell lung cancer according to K-ras genotypes. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[21] J. Herman,et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.
[22] J. Dr,et al. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia. , 1994 .
[23] J. Mate,et al. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. , 1993, Oncogene.
[24] S. Steinberg,et al. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. , 1991, Cancer research.
[25] S. Rodenhuis,et al. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. , 1991, Journal of the National Cancer Institute.
[26] C. Marshall,et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. , 1991, Cancer research.